![PRL3-zumab, a first-in-class humanized antibody for cancer therapy]()
PRL3-zumab, a first-in-class humanized antibody for cancer therapyThura, Min; Al-Aidaroos, Abdul Qader Omer; Yong, Wei Peng; Kono, Koji; Gupta, Abhishek; Lin, You Bin; Mimura, Kousaku; Thiery, Jean Paul; Goh, Boon Cher; Tan, Patrick; Soo, Ross; Hong, Cheng William; Wang, Lingzhi; Lin, Suling Joyce; Chen, Elya; Rha, Sun Young; Chung, Hyun Cheol; Li, Jie; Nandi, Sayantani; Yuen, Hiu Fung; Zhang, Shu-Dong; Guan, Yeoh Khay; So, Jimmy; Zeng, Qi · JCI Insight · 2016